Immunogen
Takeda and ImmunoGen collaborate for development and commercialisation of Elahere in Japan
August 29, 2023Sales and Marketing Elahere, Immunogen, Oncology, Takeda
ImmunoGen has announced that it has entered into an exclusive collaboration with Takeda Pharmaceutical Company for the development and commercialisation …
ImmunoGen to axe 220 positions as part of new restructuring strategy
June 28, 2019Manufacturing and Production, Medical Communications Immunogen, pharma
ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …
Isatuximab improves on standard of care treatments for multiple myeloma
June 3, 2019Sales and Marketing Cancer, Immunogen, Sanofi, isatuximab, multiple myeloma, pharma
Sanofi and ImmunoGen’s isatuximab combination therapy prolonged progression free survival by five months compared to standard of care treatments in …
ImmunoGen shares plummet by 32% after FDA recommends new Phase 3 trial
May 16, 2019Business Services, Research and Development Cancer, Immunogen, Shares, ovarian cancer, pharma, stocks
Shares in ImmunoGen fell 32% in premarket trading after the firm said the FDA had recommended a new Phase 3 …
Investigational ImmunoGen drug gives hope against platinum-resistant ovarian cancer
April 20, 2017Research and Development Cancer, Immunogen, ovarian cancer
Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an …
Takeda buys license to ImmunoGen cancer tech
March 24, 2015Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger
Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …
ImmunoGen stops cancer trial
November 6, 2013Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche
Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …
